HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

4- (4- (3- (pyridin- 2- yl)- 1H- pyrazol- 4- yl)pyridin- 2- yl)- N- (tetrahydro- 2H- pyran- 4- yl)benzamide

a TGF type I receptor antagonist; structure in first source
Also Known As:
GW 799388; GW-788388; GW788388
Networked: 5 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Khalafalla, Mahmoud G: 1 article (01/2015)
2. Weisman, Gary A: 1 article (01/2015)
3. Woods, Lucas T: 1 article (01/2015)
4. Camden, Jean M: 1 article (01/2015)
5. Erb, Laurie: 1 article (01/2015)
6. El-Sayed, Farid G: 1 article (01/2015)
7. Petris, Michael J: 1 article (01/2015)
8. Waghabi, Mariana C: 1 article (01/2012)
9. Araújo-Jorge, Tania C: 1 article (01/2012)
10. Feige, Jean-Jacques: 1 article (01/2012)

Related Diseases

1. Fibrosis (Cirrhosis)
2. Ventricular Remodeling
3. Chagas Disease (American Trypanosomiasis)
4. Diabetic Nephropathies (Diabetic Nephropathy)

Related Drugs and Biologics

1. Transforming Growth Factor beta (TGF-beta)
2. Collagen Type I (Type I Collagen)
3. Messenger RNA (mRNA)
4. Phosphotransferases (Kinase)
5. Fibronectins (Fibronectin)
6. Collagen
7. Bleomycin (Blenoxane)
8. 4- (5- benzo(1,3)dioxol- 5- yl- 4- pyridin- 2- yl- 1H- imidazol- 2- yl)benzamide
9. TGF-beta type I receptor
10. bosentan (Tracleer)

Related Therapies and Procedures

1. Oral Administration